Nature 574 , 492493 (2019)
The science of slowed gastrointestinal motility GLP-1 receptor agonists act on the gutbrain axis and are known to slow gastric emptying and overall gastrointestinal transit , contributing to early satiety and appetite suppression. As intestinal transit slows, the colon has more time to absorb water from stool , leading to hard, dry stools that are difficult to pass . Constipation is a common, dose-related adverse effect listed in FDA prescribing information for both Wegovy (semaglutide) and Zepbound (tirzepatide) and is most frequently reported during dose escalation , with improvement over time., Step-by-Step MD Protocol for Relief 1
Finally, youll meet with a provider and registered dietician
Timing Your Supplements for Maximum Benefit When you take B12 and iron can really affect how well your body absorbs them
Diabetes und Stoffwechsel
This thought led to the development of the group of drugs known as GLP-1 receptor agonists